0D1W fundamentals
An in-depth look to BIOPHYTIS EUR0.8 (POST CONSOLIDATION) operating, investing, and financing activities
0D1W free cash flow for H2 23 is -5.05 M EUR. For 2023, 0D1W free cash flow was -13.55 M EUR and operating cash flow was -13.33 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM